Jaime Sanz‐Cánovas

Metabolically healthy obesity: Inflammatory biomarkers and adipokines in elderly population

Lidia Cobos-Palacios, M. Isabel Ruiz‐Moreno, Alberto Vilches-Pérez et al. · PLoS ONE · 2022 · 34 citations · Full text

Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study

Luis M. Pérez‐Belmonte, Julio Osuna‐Sánchez, Mercedes Millán‐Gómez et al. · Annals of Medicine · 2019 · 33 citations · Full text

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

Luis M. Pérez‐Belmonte, Jaime Sanz‐Cánovas, María Dolores García de Lucas et al. · Frontiers in Endocrinology · 2022 · 30 citations · Full text

Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure

Luis M. Pérez‐Belmonte, Jaime Sanz‐Cánovas, Mercedes Millán‐Gómez et al. · Journal of the American Geriatrics Society · 2021 · 22 citations

Obesity, Diabetes, and Cardiovascular Risk Burden in Systemic Lupus Erythematosus: Current Approaches and Knowledge Gaps—A Rapid Scoping Review

Halbert Hernández-Negrín, Michele Ricci, Juan José Mancebo-Sevilla et al. · International Journal of Environmental Research and Public Health · 2022 · 21 citations · Full text

Cardiometabolic Risk, Obesity, Metabolic Syndrome +17